This is a preview of subscription content, log in via an institution to check access.
References
Arcaro A, Wymann MP (1993) Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-triphosphate in neutrophil responses. Biochem J 296, 297–301
Benistant C, Chapuis H, Roche S (2000) A specific function for phosphatidylinositol 3-kinase alpha (p85alpha-p 110alpha) in cell survival and for phosphatidylinositol 3-kinase beta (p85alpha-pll0beta) in de novo DNA synthesis of human colon carcinoma cells. Oncogene 19, 5083–5090
Bi L, Okabe I, Bernard DJ, Wynshaw-Boris A, Nussbaum RL (1999) Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase. J Biol Chem 274, 10963–10968
Christoforidis S, Miaczynska M, Ashman K, Wilm M, Zhao L et al. (1999) Phosphatidylinositol-3-OH kinases are Rab5 effectors. Nat Cell Biol 1, 249–252
Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P (1996) Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84, 911–921
Fruman DA, Meyers RE, Cantley LC (1998) Phosphoinositide kinases. Annu Rev Biochem 67, 481–507
Fruman DA, Snapper SB, Yballe CM, Davidson L, Yu JY et al. (1999) Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science 283, 393–397
Gaillard C, Strauss F (1990) Ethanol precipitation of DNA with linear polyacrylamide as carrier. Nucleic Acids Res 18, 378
Hill K, Welti S, Yu J, Murray JT, Yip SC et al. (2000) Specific requirement for the p85-pll0alpha phosphatidylinositol 3-kinase during epidermal growth factor-stimulated actin nucleation in breast cancer cells. J Biol Chem 275, 3741–3744
Hooshmand-Rad R, Hajkova L, Klint P, Karlsson R, Vanhaesebroeck B et al. (2000) The PI 3-kinase isoforms p110(alpha) and p110(beta) have differential roles in PDGF- and insulin-mediated signaling. J Cell Sci 113 Pt 2, 207–214
Hu P, Mondino A, Skolnik EY, Schlessinger J (1993) Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85. Mol Cell Biol 13, 7677–7688
Katada T, Kurosu H, Okada T, Suzuki T, Tsujimoto N et al. (1999) Synergistic activation of a family of phosphoinositide 3-kinase via G-protein coupled and tyrosine kinase-related receptors. Chem Phys Lipids 98, 79–86
Oakey RJ, Matteson PG, Litwin S, Tilghman SM, Nussbaum RL (1995) Nondisjunction rates and abnormal development in a mouse cross between heterozygotes carrying a (7, 18) robertsonian translocation. Genetics 141, 667–674
Roche S, Downward J, Raynal P, Courtneidge SA (1998) A function for phosphatidylinositol 3-kinase beta (p85alpha-pll0beta) in fibroblasts during mitogenesis: requirement for insulin- and lysophosphatidic acid-mediated signal transduction. Mol Cell Biol 18, 7119–7129
Siddhanta U, McIlroy J, Shah A, Zhang Y, Backer JM (1998) Distinct roles for the p110alpha and hVPS34 phosphatidylinositol 3−kinases in vesicular trafficking, regulation of the actin cytoskeleton, and mitogenesis. J Cell Biol 143, 1647–1659
Suzuki H, Terauchi Y, Fujiwara M, Aizawa S, Yazaki Y et al. (1999) Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science 283, 390–392
Tybulewicz VL, Tremblay ML, LaMarca ME, Willemsen R, Stubblefield BK et al. (1992) Animal model of Gaucher’s disease from targeted disruption of the mouse glucocerebrosidase gene. Nature 357, 407–410
Vanhaesebroeck B, Welham MJ, Kotani K, Stein R, Warne PH et al. (1997) P110delta, a novel phosphoinositide 3-kinase in leukocytes. Proc Natl Acad Sci USA 94, 4330–4335
Vanhaesebroeck B, Jones GE, Allen WE, Zicha D, Hooshmand-Rad R et al. (1999) Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages. Nat Cell Biol 1, 69–71
Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R et al. (2001) Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70, 535–602
Vlahos CJ, Matter WF, Hui KT, Brown RF (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-l-benzopyran-4-one (LY294002). J Biol Chem 269, 5241–5248
Wymann MP, Pirola L (1998) Structure and function of phosphoinositide 3-kinases. Biochim Biophys Acta 1436, 127–150
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bi, L., Okabe, I., Bernard, D.J. et al. Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase. Mammalian Genome 13, 169–172 (2002). https://doi.org/10.1007/BF02684023
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02684023